Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
May 28, 2020
Global Nanotechnology in Drug Delivery Markets, 2020-2027 with Profiles of 43 Industry Players
Apr 02, 2020
Camurus Announces Strong First Quarter Demand for Buvidal®
Nov 25, 2019
Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence
Nov 07, 2019
Camurus Announces That FDA Grants Braeburn's Citizen Petition, Eliminating the Risk of Further Blocking of Brixadi(TM) From the US market
Sep 24, 2019
Outlook on the Sustained Release Injectables Market to 2026 - Featuring Eli Lilly, AstraZeneca, Ipsen, Novartis, Roche, Sanofi, and More
Jul 23, 2019
Camurus Announces Positive Outcome of U.S. Court Proceeding About Final Approval of Brixadi(TM)
Jun 20, 2019
Camurus Receives IND Acceptance From the FDA to Enter Phase 3 with CAM2029 for Treatment of Acromegaly
Jun 04, 2019
Camurus Announces Publication of Phase 3 Study Results Showing Long-term Safety, Efficacy and High Rates of Patient Satisfaction With Buvidal®
May 09, 2019
Camurus Interim Report January-March 2019
Apr 09, 2019
Braeburn Initiates Court Proceedings to Overturn Exclusivity and Seeks Immediate Market Approval of Brixadi(TM) in the US
Mar 26, 2019
Driven by a Growing Pipeline of Biotherapeutics, the Drug Delivery Technologies Market is Expected to Witness a Double-digit Growth in the Foreseen Future, Predicts Roots Analysis
Dec 23, 2018
Braeburn Announces Tentative FDA Approval of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Moderate to Severe Opioid Use Disorder
Oct 31, 2018
Global Oral Mucositis (OM) Market Insights, Epidemiology and Market Forecast to 2027: Focus on United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China
Oct 10, 2018
Camurus to Present at Jefferies 2018 London Healthcare Conference
Sep 21, 2018
CHMP Recommends Approval of Buvidal® (CAM2038) for the Treatment of Opioid Dependence
Sep 21, 2018
CAM2038 Receives Positive CHMP Opinion for the Treatment of Opioid Dependence in Europe
Sep 18, 2018
Global Bio-Adhesive Market 2018-2022 with Snapshot of the US and India Markets
Sep 18, 2018
Camurus Announces Positive Topline Phase 3 Results for CAM2038 in Opioid Experienced Patients With Chronic Low-back Pain
Jul 16, 2018
Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder